Skip to content

Financial Strategy Guide for CFOs: Thrive Immediately, Gain Profit Eventually (Extract from August Feature Story)

Restructuring costs and strategic scaling are imperative for CFOs to successfully implement Hospital at Home models.

Financial Strategy Guide for CFOs: Endure Present Challenges, Secure Future Profits (Extract from...
Financial Strategy Guide for CFOs: Endure Present Challenges, Secure Future Profits (Extract from August's Feature Story)

Financial Strategy Guide for CFOs: Thrive Immediately, Gain Profit Eventually (Extract from August Feature Story)

In the evolving landscape of healthcare, Hospital-at-Home (HaH) programs are gaining traction as a long-term capacity and care transformation play, rather than a short-term cost cutter. However, these programs face several financial challenges, particularly for smaller health systems.

According to industry expert Bryant, HaH should not be treated like a pilot, and CFOs must get payer relationships lined up on the front end to avoid financial and operational challenges. The financial sustainability of HaH programs is at risk without the Centers for Medicare & Medicaid Services (CMS) waiver, which is set to expire later this year.

The competitive market for HaH is unique, with the "competition" being death and disease. Dr. Gandhi, a prominent figure in the field, highlights this point. The CMS waiver is crucial for reimbursement of most HaH programs. Losing traditional Medicare coverage would significantly shrink patient volumes, potentially leading to the collapse of HaH programs and straining operations.

CFO engagement is essential for scalable and profitable growth in HaH. Program designers must design ground-up financial frameworks that isolate true HaH costs, as traditional hospital overhead models distort the Return on Investment (ROI) for these programs.

Bryant recommends using external partners to launch HaH programs but being ready to pivot when that partnership no longer adds value. Strong executive and physician backing is critical to the success of these programs, as demonstrated by UNC Health's HaH program, which emphasized the importance of building a scalable model to reach at least 30 patients daily.

Negotiating with payers when care decisions are dictated by insurance rather than clinical appropriateness can be difficult. The winners in the HaH market will be the CFOs who resist overengineering, scale deliberately, and make bold, sustained investments in infrastructure, workforce, and payer alignment.

Programs without the CMS waiver would face higher administrative burdens and payer eligibility checks, straining operations and frustrating clinicians. Programs serving fewer than 30-60 patients per day often cannot reach the cost efficiencies needed to compete with inpatient care.

While specific CFOs responsible for the success of HaH models and the healthcare companies that implemented these programs are not detailed in the provided search results, prominent healthcare firms like Fresenius, a major German healthcare provider, focus on developing core healthcare services and may be involved in such innovative care models.

Bryant emphasizes the value of HaH programs in terms of great outcomes, exceptional patient experience, lower readmission rates, and higher patient satisfaction. By navigating these financial challenges, CFOs can contribute to the success of HaH programs and improve the overall healthcare landscape.

Read also: